Andere talen Shuttle Pharmaceuticals Holdings, Inc.

Aandelen

SHPH

US8256932034

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 31-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,531 ^USD	-.--%		+24,50%	+16,70%

13/05	Shuttle Pharmaceuticals Holdings, Inc. Rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
21/03	Shuttle Pharmaceuticals Holdings, Inc. Rapporteert winstresultaten voor het volledige jaar eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma	08/01
Shuttle Pharmaceuticals Holdings, Inc. Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma	11/12
Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Shuttle Pharma Announces Results of Pre-IND Meeting with FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma	25-09-23
Shuttle Pharmaceuticals Holdings, Inc. Expands Patent Coverage on HDAC Inhibitor Platform	11-09-23
Top Premarket Gainers	08-09-23
Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23
Shuttle Pharmaceuticals Completes Manufacturing of Active Pharmaceutical Ingredient for Use in Clinical Trial	03-08-23
Top Premarket Gainers	26-05-23
Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	25-05-23
Shuttle Pharmaceuticals, Georgetown University Sign Research Deal to Evaluate Anti-Tumor Candidates	22-03-23
Shuttle Pharmaceuticals Holdings, Inc. Auditor Raises 'Going Concern' Doubt	15-03-23
Shuttle Pharmaceuticals Signs Ropidoxuridine Manufacturing Deal With University of Iowa Pharmaceuticals	09-03-23
Shuttle Pharmaceuticals Expands Laboratory Space to Advance Drug Development Pipeline and Diagnostic Capabilities	23-02-23
Sector Update: Health Care Stocks Steady Friday Afternoon While Other Sectors Rebound	13-01-23
Sector Update: Health Care Standing Firm as Broader Markets Catch Up	13-01-23
Sector Update: Health Care	13-01-23
Sector Update: Health Care Stocks Mixed Pre-Bell Friday	13-01-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Shuttle Pharmaceuticals Holdings, Inc.

Aandelen

SHPH

US8256932034

Andere talen

Filters